Intuitive Surgical, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-78.4% vs price
Base Case (Median)
-68.7% vs price
Bull Case (75th pct.)
-47.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $31.26 | -91.2% | High (40%) |
| PE Comparable | $195.70 | -45.2% | Medium (25%) |
| Growth Trajectory DCF | $239.25 | -33.0% | Medium (20%) |
| Graham Number | $99.38 | -72.1% | Medium (40%) |
| EV/EBITDA | $111.75 | -68.7% | Medium (20%) |
| EV/FCF | $180.59 | -49.4% | Medium (20%) |
| Earnings Power Value | $54.80 | -84.6% | Medium (50%) |
Based on 7 out of 8 methods, ISRG appears overvalued at the current price of $356.83. The base case fair value of $111.75 implies 68.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.